| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5705051 | Ophthalmology | 2017 | 14 Pages |
Abstract
Allotopic gene therapy for LHON at low and medium doses seems to be safe and does not damage the temporal retinal nerve fiber layer, opening the door next for testing of the high dose.
Keywords
RGCPERGETDRSNaBlogMARLHONRNFLNeutralizing antibodypattern electroretinographyOctOptical coherence tomographyGEEhand movementsearly treatment diabetic retinopathy studyretinal ganglion cellRetinal nerve fiber layerlogarithm of the minimum angle of resolutiongeneralized estimating equationLeber hereditary optic neuropathy
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
John MD, William J. MS, Janet L. MD, Vittorio PhD, Phillip J. CCRP, Rajeshwari D. PhD, Huijun PhD, William W. PhD, Byron L. MD,